Novel Combination Therapy Offers Hope for Immunotherapy-Resistant Aggressive Lymphoma
In a groundbreaking advancement for the treatment of relapsed or refractory natural killer/T-cell lymphoma (R/R NKTL), researchers have unveiled a promising therapeutic approach that strategically...